TEM.NASDAQTempus Ai, INC

Form 4: Tempus AI Executes Significant Transactions in Personalis, Inc. Stock and Warrants

Sentiment:

SEC Form 4 Filing


Tempus AI, a 10% owner of Personalis, Inc., reports acquiring and disposing of common stock and warrants in a series of transactions on August 16, 2024.

Summary

  • On August 16, 2024, Tempus AI, Inc. engaged in multiple transactions involving Personalis, Inc. (PSNL) common stock and warrants.
  • Tempus AI disposed of 4,609,400 shares of common stock at $1.50 and another 4,609,400 shares at $2.50.
  • Concurrently, Tempus AI acquired 3,500,000 shares of common stock at $5.07.
  • Following these transactions, Tempus AI holds 12,718,800 shares of Personalis, Inc. common stock.
  • Tempus AI also disposed of warrants to purchase 4,609,400 shares of common stock at an exercise price of $1.50 and warrants to purchase 4,609,400 shares of common stock at an exercise price of $2.50.
  • The warrants were acquired as partial consideration for obligations under a Commercialization and Reference Laboratory Agreement dated November 25, 2023.

Sentiment

Score: 5

Explanation: The document is a factual report of stock and warrant transactions. The sentiment is neutral as it simply describes the events without expressing any positive or negative opinions.

Industry Context

This Form 4 filing indicates significant trading activity by a major shareholder, Tempus AI, in Personalis, Inc. Understanding the reasons behind these transactions requires further investigation into the relationship between the two companies and the broader market conditions.

Related Party Transactions

  • The warrants were acquired as partial consideration for obligations under a Commercialization and Reference Laboratory Agreement between Personalis, Inc. and Tempus AI, Inc., indicating a related party transaction.

Stakeholder Impact

  • The transactions could impact Personalis, Inc. shareholders due to the change in ownership and potential market reaction to the trading activity of a major shareholder.

Key Dates

DateDescription
11/25/2023Date of the Commercialization and Reference Laboratory Agreement between Personalis, Inc. and Tempus AI, Inc.
08/16/2024Date of the transactions involving Personalis, Inc. common stock and warrants.
08/20/2024Date of signature of the Form 4 report.
12/31/2024Expiration date of some warrants.
12/31/2025Expiration date of some warrants.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.